Herceptin 440mg Injection (Trastuzumabum) – Complete Product Description

Herceptin 440mg Injection (Trastuzumabum) is a prescription oncology medicine manufactured by Roche. It contains trastuzumab, a recombinant humanized monoclonal antibody designed to target the HER2 (human epidermal growth factor receptor 2) protein. Herceptin is an important targeted cancer therapy used for patients with HER2-positive cancers, particularly certain types of breast cancer and gastric or gastroesophageal junction cancer.

Herceptin 440mg is supplied as a powder for preparation of an intravenous infusion and is intended for administration by qualified healthcare professionals. The product listed here is manufactured by Roche and supplied in a pack size of 1 injection.

Trastuzumab specifically binds to the HER2 receptor and helps inhibit HER2-mediated signaling that can contribute to the growth and survival of cancer cells. It may also help the immune system identify and destroy HER2-expressing cancer cells.

Herceptin 440mg Injection – Product Information

Brand Name: Herceptin
Active Ingredient: Trastuzumabum (Trastuzumab)
Strength: 440mg
Dosage Form: Powder for concentrate/solution for intravenous infusion
Route of Administration: Intravenous (IV) infusion
Manufacturer: Roche
Pack Size: 1 injection
Drug Class: HER2-targeted monoclonal antibody
Therapeutic Class: Antineoplastic / Targeted cancer therapy
Prescription Status: Prescription medicine

Herceptin is a specialized biological medicine. It should be reconstituted, prepared and administered by appropriately trained healthcare professionals.

What Is Herceptin 440mg Injection Used For?

Herceptin (trastuzumab) is used to treat selected cancers in patients whose tumors demonstrate HER2 overexpression or HER2 amplification, depending on the approved indication and treatment setting.

Herceptin may be used for:

• HER2-positive breast cancer
• Early-stage HER2-positive breast cancer
• HER2-positive metastatic breast cancer
• HER2-positive metastatic gastric cancer
• HER2-positive gastroesophageal junction cancer

Treatment may involve Herceptin alone or in combination with chemotherapy, endocrine therapy or other medicines, depending on the cancer type and treatment plan.

Herceptin for HER2-Positive Breast Cancer

Herceptin is widely used in the treatment of HER2-positive breast cancer. HER2-positive breast cancers have increased amounts of the HER2 protein or gene amplification, which can promote cancer-cell growth.

Depending on the disease stage and treatment setting, trastuzumab may be used before surgery, after surgery or for advanced/metastatic disease.

The treatment regimen is selected by the oncologist based on tumor characteristics, stage, previous treatment and the patient’s overall health.

Herceptin for Early Breast Cancer

For appropriately selected patients with HER2-positive early breast cancer, trastuzumab may be incorporated into treatment before and/or after surgery.

It can be combined with chemotherapy and may be continued for an appropriate duration according to the prescribed treatment protocol.

Herceptin for Metastatic Breast Cancer

Herceptin can be used for patients with HER2-positive metastatic breast cancer. Depending on the patient’s treatment history, trastuzumab may be administered with other anticancer medicines or used as part of a combination treatment regimen.

Herceptin for Gastric Cancer

Trastuzumab may also be used in selected patients with HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma.

HER2 testing is important when determining whether trastuzumab-based treatment is appropriate.

How Does Herceptin (Trastuzumab) Work?

Herceptin contains trastuzumab, a targeted monoclonal antibody that specifically binds to the HER2 receptor.

HER2 is a protein found on the surface of certain cells. In some cancers, HER2 is present at abnormally high levels or the HER2 gene is amplified. This can promote cancer-cell growth and survival.

Trastuzumab binds to HER2 and interferes with HER2-related signaling. It can also stimulate immune mechanisms that help destroy HER2-expressing cancer cells.

Because Herceptin specifically targets the HER2 pathway, it is considered a targeted biological cancer therapy rather than conventional chemotherapy.

HER2 Testing Before Herceptin Treatment

Herceptin is intended for patients whose tumors meet the appropriate criteria for HER2-targeted treatment.

Doctors may use laboratory tests such as immunohistochemistry (IHC) and/or in situ hybridization (ISH) to determine HER2 status.

Your oncologist will review the pathology report and other clinical information to determine whether trastuzumab is appropriate.

Herceptin 440mg Dose and Administration

Herceptin 440mg is administered by intravenous infusion after appropriate preparation and dilution.

The exact dose and treatment schedule depend on:

• Type of cancer
• Stage of disease
• Treatment setting
• Patient’s body weight
• Previous treatment
• Other medicines used with trastuzumab
• Individual medical condition

Trastuzumab may be administered using a loading dose followed by maintenance doses. The interval between doses varies according to the approved treatment regimen.

Herceptin should only be administered by a qualified healthcare professional.

Do not attempt to self-inject Herceptin 440mg.

Common Side Effects of Herceptin 440mg

Like all prescription medicines, Herceptin may cause side effects. Some adverse reactions are related to the immune response, infusion process or effects on the heart.

Possible side effects include:

• Fever
• Chills
• Headache
• Nausea
• Vomiting
• Diarrhea
• Fatigue
• Weakness
• Muscle pain
• Joint pain
• Cough
• Shortness of breath
• Rash
• Infusion-related reactions

The severity of side effects can vary from patient to patient.

Serious Side Effects of Herceptin

Although many patients tolerate trastuzumab well, serious adverse reactions can occur.

Heart Problems

One of the most important risks associated with trastuzumab is cardiac dysfunction, including reduced left ventricular ejection fraction and, in some cases, congestive heart failure.

Heart function may therefore be evaluated before and during treatment.

Patients should immediately report symptoms such as:

• New or worsening shortness of breath
• Swelling of the legs or ankles
• Unusual fatigue
• Rapid or irregular heartbeat
• Sudden weight gain

Infusion-Related Reactions

Herceptin can cause infusion-related reactions, particularly during or shortly after administration.

Symptoms may include:

• Fever
• Chills
• Headache
• Dizziness
• Nausea
• Difficulty breathing
• Low or high blood pressure
• Wheezing

Healthcare professionals monitor patients during infusion and manage reactions according to their severity.

Lung Problems

Serious pulmonary reactions can occur rarely. New or worsening breathing difficulties should be reported promptly.

Precautions Before Using Herceptin

Before starting Herceptin treatment, inform your doctor if you have:

• A history of heart disease
• Heart failure
• High blood pressure
• Previous treatment with anthracycline chemotherapy
• Lung disease
• Previous severe infusion reactions
• Any known allergy to trastuzumab or related medicines

Your healthcare provider should also know about all prescription medicines, over-the-counter medicines, supplements and other cancer treatments you are taking.

Herceptin and Heart Monitoring

Because trastuzumab can affect cardiac function, your healthcare provider may perform heart assessments before and during treatment.

Tests may include:

• Echocardiogram
• MUGA scan
• Other cardiac assessments as clinically appropriate

Patients with pre-existing heart disease or significant cardiac risk factors may require particularly careful monitoring.

Herceptin During Pregnancy

Herceptin can cause fetal harm when administered during pregnancy. Women who are pregnant or planning to become pregnant should discuss treatment risks with their healthcare provider.

Patients who can become pregnant should follow their healthcare professional’s recommendations regarding effective contraception during treatment and for the appropriate period following the final dose.

If pregnancy occurs during Herceptin treatment, contact the treating healthcare professional promptly.

Herceptin and Breastfeeding

Patients should discuss breastfeeding with their healthcare provider before receiving Herceptin.

Because trastuzumab is a specialized biological medicine with potential risks to a breastfed infant, the treating physician will advise whether breastfeeding should be avoided during treatment and for the recommended period afterward.

Herceptin 440mg Storage

Herceptin is a biological medicine that requires appropriate storage and handling.

The unopened product should be stored according to the manufacturer’s approved storage conditions and protected from inappropriate temperatures and light.

Do not freeze the product unless specifically permitted by the official product instructions.

Once prepared, the reconstituted and diluted solution must be handled according to approved pharmaceutical preparation requirements.

Herceptin should be prepared and administered by trained healthcare professionals.

Herceptin 440mg Injection Price in Pakistan

The Herceptin 440mg Injection price in Pakistan may vary depending on availability, supplier, import costs, exchange rates and prevailing market conditions.

For the latest Herceptin 440mg price in Pakistan, customers can contact MedicineWalyDost.com to check current availability and pricing.

Because oncology medicines can have changing market prices, it is recommended to confirm the current price before placing an order.

Why Choose Herceptin 440mg Injection?

Herceptin contains trastuzumab, a well-established HER2-targeted monoclonal antibody used in appropriately selected patients with HER2-positive cancers.

The Roche-manufactured Herceptin 440mg presentation is designed for intravenous treatment under professional medical supervision.

Its targeted mechanism allows oncologists to specifically address the HER2 pathway in cancers where HER2 overexpression or amplification has been confirmed.

Frequently Asked Questions About Herceptin 440mg

What is Herceptin 440mg Injection?

Herceptin 440mg Injection is a prescription oncology medicine containing trastuzumab, a HER2-targeted monoclonal antibody used for selected HER2-positive cancers.

What is the generic name of Herceptin?

The generic name is trastuzumab. The term Trastuzumabum may also appear in product or pharmaceutical naming.

Who manufactures Herceptin 440mg?

The manufacturer of the product listed here is Roche.

What is the pack size of Herceptin 440mg?

The pack size for this product is 1 injection.

How is Herceptin 440mg administered?

Herceptin 440mg is prepared and administered by intravenous infusion under the supervision of a qualified healthcare professional.

What is Herceptin used for?

Herceptin is used for selected HER2-positive breast cancers and certain HER2-positive gastric or gastroesophageal junction cancers, depending on the approved indication and patient’s treatment plan.

Is Herceptin chemotherapy?

Herceptin is not traditional chemotherapy. It is a targeted biological therapy and monoclonal antibody that specifically targets the HER2 receptor. It may be used in combination with chemotherapy.

Does Herceptin require HER2 testing?

Yes. HER2 status is an important factor in determining whether trastuzumab treatment is appropriate. Appropriate laboratory testing is generally performed before treatment.

Can Herceptin be purchased without a prescription?

Herceptin is a specialized prescription oncology medicine and should only be used under the supervision of a qualified oncologist or healthcare professional.

Order Herceptin 440mg Injection in Pakistan

Looking for Herceptin 440mg Injection (Trastuzumabum) by Roche in Pakistan?

MedicineWalyDost.com offers access to specialized prescription medicines and oncology products. Contact us to check the latest Herceptin 440mg price, availability and ordering information.

Before ordering, confirm the brand name, strength, active ingredient, manufacturer, pack size and prescription requirements with your doctor or pharmacist.

Order Herceptin 440mg Injection from MedicineWalyDost.com and contact us today for current availability and pricing.

Important Medical Disclaimer

Herceptin 440mg Injection is a prescription cancer medicine. This information is intended for educational and product-description purposes only and does not replace professional medical advice. Herceptin should be prescribed and administered by a qualified healthcare professional. Do not change the dose, treatment schedule or duration without medical advice.